Shanen M. Sherrer

Shanen M. Sherrer

Auto-generated profile, based on publicly available information

Shanen M. Sherrer

Department of Chemistry and Biochemistry, St. Mary’s College of Maryland, St. Mary’s City, MD 20686

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JMJessica L. Malisch
Jessica L. Malisch
BHBreanna N Harris
Breanna N Harris
SSShanen M. Sherrer
Shanen M. Sherrer
KLKristy A. Lewis
Kristy A. Lewis
SSStephanie L. Shepherd
Stephanie L. Shepherd
JDJennifer Deitloff
Jennifer Deitloff

1 January 2010 in Journal of Molecular Biology
Verified
Journal Article
Closed access
JBJessica A. Brown
Jessica A. Brown
KFKevin A. Fiala
Kevin A. Fiala
JFJason D. Fowler
Jason D. Fowler
SSShanen M. Sherrer
Shanen M. Sherrer
SNSean A. Newmister
Sean A. Newmister
ZSZucai Suo
Zucai Suo

14 February 2008 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
KFKevin A. Fiala
Kevin A. Fiala
SSShanen M. Sherrer
Shanen M. Sherrer
JBJessica A. Brown
Jessica A. Brown
ZSZucai Suo
Zucai Suo
Our previous publication shows that Sulfolobus solfataricus Dpo4 utilizes an ‘induced-fit’ mechanism to select correct incoming nucleotides at 37 ° C. Here, we provide a comprehensive report elucidating the kinetic mechanism of a DNA polymerase at a reaction temperature higher than 37 ° C in an attempt to determine the effect of temperature on enzyme fidelity and mechanism. The fidelity of Dpo4 did not change considerably with a 30 ° C increase in reaction temperature, suggesting that the fidelity of Dpo4 at 80 ° C is similar to that determined here at 56 ° C. Amazingly, the incorporation rate for correct nucleotides increased by 18 900-fold from 2 ° C to 56 ° C, similar in magnitude to that observed for incorrect nucleotides, thus not perturbing fidelity. Three independent lines of kinetic evidence indicate that a protein conformational change limits correct nucleotide incorporations at 56 ° C. Furthermore, the activation energy for the incorporation of a correct nucleotide was determined to be 32.9 kcal/mol, a value considerably larger than those values estimated for a rate-limiting chemistry step, providing a fourth line of evidence to further substantiate this conclusion. These results herein provide evidence that Dpo4 utilizes the ‘induced-fit’ mechanism to select a correct nucleotide at all temperatures.

1 March 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SSShanen M. Sherrer
Shanen M. Sherrer
JBJessica A. Brown
Jessica A. Brown
LPLindsey R. Pack
Lindsey R. Pack
VJVijay P. Jasti
Vijay P. Jasti
JFJason D. Fowler
Jason D. Fowler
ZSZucai Suo
Zucai Suo
1-Nitropyrene, the most abundant nitro polycyclic aromatic hydrocarbon in diesel emissions, has been found to react with DNA to form predominantly N-(deoxyguanosin-8-yl)-1-aminopyrene (dGAP). This bulky adduct has been shown to induce genetic mutations, which may implicate Y-family DNA polymerases in its bypass in vivo. To establish a kinetic mechanism for the bypass of such a prototype single-base lesion, we employed pre-steady-state kinetic methods to investigate individual nucleotide incorporations upstream, opposite, and downstream from a site-specifically placed dGAP lesion catalyzed by Sulfolobus solfataricus DNA polymerase IV (Dpo4), a model Y-family DNA polymerase. Dpo4 was able to bypass dGAP but paused strongly at two sites: opposite the lesion and immediately downstream from the lesion. Both nucleotide incorporation efficiency and fidelity decreased significantly at the pause sites, especially during extension of the bypass product. Interestingly, a 4-fold tighter binding affinity of damaged DNA to Dpo4 promoted catalysis through putative interactions between the active site residues of Dpo4 and 1-aminopyrene moiety at the first pause site. In the presence of a DNA trap, the kinetics of nucleotide incorporation at these sites was biphasic in which a small, fast phase preceded a larger, slow phase. In contrast, only a large, fast phase was observed during nucleotide incorporation at non-pause sites. Our kinetic studies support a general kinetic mechanism for lesion bypass catalyzed by numerous DNA polymerases.

15 September 2010 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
SSShanen M. Sherrer
Shanen M. Sherrer
KFKevin A. Fiala
Kevin A. Fiala
JFJason D. Fowler
Jason D. Fowler
SNSean A. Newmister
Sean A. Newmister
JPJohn M. Pryor
John M. Pryor
ZSZucai Suo
Zucai Suo
Higher eukaryotes encode various Y-family DNA polymerases to perform global DNA lesion bypass. To provide complete mutation spectra for abasic lesion bypass, we employed short oligonucleotide sequencing assays to determine the sequences of abasic lesion bypass products synthesized by human Y-family DNA polymerases eta (hPolη), iota (hPolι) and kappa (hPolκ). The fourth human Y-family DNA polymerase, Rev1, failed to generate full-length lesion bypass products after 3 h. The results indicate that hPolι generates mutations with a frequency from 10 to 80% during each nucleotide incorporation event. In contrast, hPolη is the least error prone, generating the fewest mutations in the vicinity of the abasic lesion and inserting dAMP with a frequency of 67% opposite the abasic site. While the error frequency of hPolκ is intermediate to those of hPolη and hPolι, hPolκ has the highest potential to create frameshift mutations opposite the abasic site. Moreover, the time (t 50bypass ) required to bypass 50% of the abasic lesions encountered by hPolη, hPolι and hPolκ was 4.6, 112 and 1 823 s, respectively. These t 50bypass values indicate that, among the enzymes, hPolη has the highest abasic lesion bypass efficiency. Together, our data suggest that hPolη is best suited to perform abasic lesion bypass in vivo .

25 June 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SSShanen M. Sherrer
Shanen M. Sherrer
EPElisabeth Penland
Elisabeth Penland
PMPaul Modrich
Paul Modrich
MutLα (MLH1-PMS2 heterodimer), which acts as a strand-directed endonuclease during the initiation of eukaryotic mismatch repair, has been postulated to function as a zinc-dependent enzyme [Kosinski J, Plotz G, Guarné A, Bujnicki JM, Friedhoff P (2008) J Mol Biol 382:610–627]. We show that human MutLα copurifies with two bound zinc ions, at least one of which resides within the endonuclease active site, and that bound zinc is required for endonuclease function. Mutagenic action of the carcinogen cadmium, a known inhibitor of zinc-dependent enzymes, is largely due to selective inhibition of mismatch repair [Jin YH, et al. (2003) Nat Genet 34:326–329]. We show that cadmium is a potent inhibitor (apparent Ki ∼ 200 nM) of MutLα endonuclease and that cadmium inhibition is reversed by zinc. We also show that inhibition of mismatch repair in cadmium-treated nuclear extract is significantly reversed by exogenous MutLα but not by MutSα (MSH2-MSH6 heterodimer) and that MutLα reversal depends on integrity of the endonuclease active site. Exogenous MutLα also partially rescues the mismatch repair defect in nuclear extract prepared from cells exposed to cadmium. These findings indicate that targeted inhibition of MutLα endonuclease contributes to cadmium inhibition of mismatch repair. This effect may play a role in the mechanism of cadmium carcinogenesis. Significance MutLα (MLH1-PMS2 heterodimer) is an endonuclease that acts during an early step of eukaryotic mismatch repair. We show that human MutLα endonuclease copurifies with two equivalents of bound zinc, at least one of which resides within the endonuclease active site. We also show that cadmium, a known inhibitor of zinc-dependent enzymes and a potent mutagen and carcinogen, is a high-affinity inhibitor of MutLα endonuclease and that exogenous MutLα significantly reverses the mismatch repair defect in cadmium-treated human cell nuclear extract or nuclear extract prepared from cadmium-treated cells. Because the mutagenic action of cadmium is largely due to the selective inhibition of mismatch repair, these findings suggest that MutLα is a primary cadmium target for mutagenesis and presumably, carcinogenesis as well.